<DOC>
	<DOCNO>NCT01561807</DOCNO>
	<brief_summary>The purpose study determine antiviral activity safety VX-787 give healthy adult volunteer inoculate influenza virus .</brief_summary>
	<brief_title>A Study Investigate VX-787 Given Adult Volunteers Inoculated With Live Influenza Virus</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>Negative human immunodeficiency virus ( HIV ) , hepatitis B ( HBV ) hepatitis C ( HCV ) antibody screen Have vaccinate influenza virus since 2006 known influenzalike illness current season ( determined medical history ) , define last 12 month Screening Subjects pregnant nursing , male female partner pregnant , nursing , plan become pregnant study period ( least 14 day first dose 90 day last dose study drug ) Presence significant acute chronic , uncontrolled medical psychiatric illness Abnormal pulmonary function evidence clinically significant abnormality spirometry Health care worker ( include doctor , nurse , medical student ally healthcare professional ) anticipate patient contact within two week viral inoculation Intending travel ( country vaccination recommend high risk infection exists ) Subjects history asthma , COPD , pulmonary hypertension , reactive airway disease , chronic lung condition etiology ; history adulthood asthma etiology , COPD , use bronchodilator asthma medication adulthood Regular daily smoker History evidence autoimmune disease know impaired immune responsiveness History heart failure severe cardiac abnormality include clinically significant arrhythmia Receipt investigational drug within 3 month , prior participation clinical trial influenza vaccine , medication , experimental respiratory viral challenge deliver directly respiratory tract within 1 year viral inoculation Previous exposure study drug similar substance ( )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>